Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis and a risk of progression to acute myeloid leukemia (AML). A subset of MDS patients carries mutations in the isocitrate dehydrogenase-1 (IDH1) gene, which alters cellular metabolism and contributes to leukemogenesis. Identifying and targeting the IDH1 mutation has become a